|
Quotes & Info
|
| ASTX > SEC Filings for ASTX > Form 8-K on 12-Dec-2012 | All Recent SEC Filings |
12-Dec-2012
Change in Directors or Principal Officers
Bonuses for Executive Officers On December 6, 2012, the Astex Pharmaceuticals Compensation Committee approved cash bonus awards to the executive officers of the company for their performance in calendar year 2012. The approved cash bonuses are as follows: Name and Position Bonus James S.J. Manuso, PhD $575,000 Chief Executive Officer Harren Jhoti, PhD (1) £152,903 President Mohammad Azab, MD $248,000 Chief Medical Officer Martin Buckland, DPhil (1) £85,806 Chief Business Officer Michael Molkentin $198,000 Chief Financial Officer |
|
|